These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicity. Slavin MA; Hoy JF; Stewart K; Pettinger MB; Lucas CR; Kent SJ AIDS; 1992 Oct; 6(10):1169-74. PubMed ID: 1466849 [TBL] [Abstract][Full Text] [Related]
49. [Pentamidine inhalation for Pneumocystis carinii pneumonia in AIDS]. Pines A; Giladi M; Moshkowitz M; Finkelstein A; Levo Y Harefuah; 1989 Mar; 116(6):311-2. PubMed ID: 2786489 [TBL] [Abstract][Full Text] [Related]
50. Intramuscular pentamidine for the prevention of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. Cheung TW; Matta R; Neibart E; Hammer G; Chusid E; Sacks HS; Szabo S; Rose D Clin Infect Dis; 1993 Jan; 16(1):22-5. PubMed ID: 8448314 [TBL] [Abstract][Full Text] [Related]
51. Aerosolized pentamidine as alternative primary prophylaxis against Pneumocystis carinii pneumonia in adult hepatic and renal transplant recipients. Saukkonen K; Garland R; Koziel H Chest; 1996 May; 109(5):1250-5. PubMed ID: 8625676 [TBL] [Abstract][Full Text] [Related]
52. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Opravil M; Hirschel B; Lazzarin A; Heald A; Pechère M; Rüttimann S; Iten A; von Overbeck J; Oertle D; Praz G Clin Infect Dis; 1995 Mar; 20(3):531-41. PubMed ID: 7756472 [TBL] [Abstract][Full Text] [Related]
53. Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. Vasconcelles MJ; Bernardo MV; King C; Weller EA; Antin JH Biol Blood Marrow Transplant; 2000; 6(1):35-43. PubMed ID: 10707997 [TBL] [Abstract][Full Text] [Related]
54. Bilateral upper lobe Pneumocystis carinii pneumonia in a patient receiving inhaled pentamidine prophylaxis. Abd AG; Nierman DM; Ilowite JS; Pierson RN; Bell AL Chest; 1988 Aug; 94(2):329-31. PubMed ID: 3260848 [TBL] [Abstract][Full Text] [Related]
55. Domiciliary nebulized pentamidine for secondary prophylaxis against Pneumocystis carinii pneumonia. Green ST; Nathwani D; Christie PR; Goldberg DJ; Kennedy DH; Love WC J R Soc Med; 1990 Jan; 83(1):18-9. PubMed ID: 2304047 [TBL] [Abstract][Full Text] [Related]
56. Aerosolised pentamidine for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Weinberg A; Dantonio SA; Duarte MI; Pedreira Júnior WL; Barone AA; Ishioka S Rev Inst Med Trop Sao Paulo; 1990; 32(4):289-95. PubMed ID: 2101523 [TBL] [Abstract][Full Text] [Related]
57. Aerosolized pentamidine in Pneumocystis carinii pneumonia. On A Conn Med; 1990 Mar; 54(3):140-1. PubMed ID: 2182285 [TBL] [Abstract][Full Text] [Related]
58. Pneumothoraces and Pneumocystis carinii pneumonia in two AIDS patients receiving aerosolized pentamidine. Scannell KA Chest; 1990 Feb; 97(2):479-80. PubMed ID: 2298076 [TBL] [Abstract][Full Text] [Related]
59. Effect of aerosolized pentamidine prophylaxis on the clinical severity and diagnosis of Pneumocystis carinii pneumonia. Fahy JV; Chin DP; Schnapp LM; Steiger DJ; Schaumberg TH; Geaghan SM; Klein JS; Hopewell PC Am Rev Respir Dis; 1992 Oct; 146(4):844-8. PubMed ID: 1416408 [TBL] [Abstract][Full Text] [Related]
60. Lack of desensitization to aerosol pentamidine with long-term use. Rawji A; Lee-Pack LR; Favell K; Chan CK J Aerosol Med; 1996; 9(2):241-8. PubMed ID: 10163353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]